Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Forecast: What Value Will The Market Reach By 2030?
The market size for endoscopic ultrasound (eus)-guided fine needle aspiration has demonstrated robust growth in recent years. It is forecast to increase from $0.7 billion in 2025 to $0.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. The expansion observed during past periods can be attributed to factors such as the limited availability of specialized eus-fna needles, continued reliance on conventional biopsy methods, increasing awareness of early cancer detection, growing adoption by hospitals and clinics, and the standardization of endoscopic ultrasound procedures.
The endoscopic ultrasound (eus)-guided fine needle aspiration market is projected to experience substantial growth in the upcoming years. It is anticipated to reach $1.06 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. The expansion during the forecast period can be attributed to technological advancements in powered EUS-FNA needles, the increasing prevalence of pancreatic and gastrointestinal cancers, the proliferation of gastroenterology and oncology clinics, a growing demand for minimally invasive procedures, and the integration with advanced imaging and robotics. Major trends observed in this period include a rising adoption of minimally invasive diagnostic procedures, the increasing utilization of EUS-FNA in oncology and gastroenterology, growth in the development of both powered and manual fine needle aspiration needles, the expansion of specialty clinics and ambulatory surgical centers, and a focus on achieving enhanced sample accuracy and reducing patient discomfort.
Get A Free Sample Report With In-Depth Market Insights:
Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Growth Factors: What’s Supporting Expansion?
The increasing occurrence of pancreatic conditions is projected to boost the expansion of the endoscopic ultrasound (EUS)-guided fine needle aspiration market moving ahead. Pancreatic disorders encompass various ailments and states affecting the pancreas, including inflammation, tumors, and functional impairments that impact digestion and hormone production. The prevalence of pancreatic disorders is rising, primarily due to the growing incidence of diabetes, which places additional strain on the pancreas and contributes to both inflammatory and functional pancreatic conditions. Endoscopic ultrasound (EUS)-guided fine needle aspiration proves valuable in managing pancreatic disorders by enabling minimally invasive, accurate sampling of pancreatic lesions, assisting in the diagnosis of conditions such as cancer, cysts, and chronic pancreatitis. For example, in February 2025, according to Cancer Australia, an Australia-based government agency, pancreatic cancer caused 3,687 deaths in Australia in 2022 (1,912 males and 1,775 females), a number which escalated to 3,902 deaths in 2024 (2,027 males and 1,875 females). Thus, the rising incidence of pancreatic disorders is a major factor propelling the growth of the endoscopic ultrasound (EUS)-guided fine needle aspiration market.
Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Segment Performance And Emerging Opportunities
The endoscopic ultrasound (eus)-guided fine needle aspiration market covered in this report is segmented –
1) By Needle Type: Enteral Endoscopic Ultrasound Needles, Bronchial Endoscopic Ultrasound Needles
2) By Product Type: Manual Endoscopic Ultrasound-Guided Fine Needle Aspiration (FNA) Needles, Powered Endoscopic Ultrasound-Guided Fine Needle Aspiration (FNA) Needles, Accessories For Endoscopic Ultrasound-Fine Needle Aspiration (FNA) Procedures, Sample Collection Devices
3) By Procedure Type: Endoscopic Ultrasound-Guided Fine Needle Aspiration (FNA) For Tumor Diagnosis, Endoscopic Ultrasound-Guided Fine Needle Aspiration (FNA) For Cystic Lesions, Endoscopic Ultrasound-Guided Fine Needle Aspiration (FNA) For Lymph Node Biopsies, Endoscopic Ultrasound-Guided Fine Needle Aspiration (FNA) For Solid Organ Biopsies
4) By Application: Gastroenterology, Oncology, Pulmonology, Endocrinology
5) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
Subsegments:
1) By Enteral Endoscopic Ultrasound Needles: Aspiration Needles, Biopsy Needles, Core Needles, Fine Needle Biopsy (FNB) Needles, Fine Needle Aspiration (FNA) Needles
2) By Bronchial Endoscopic Ultrasound Needles: Transbronchial Aspiration Needles, Biopsy Needles, Echoendoscopic Fine Needles, Fine Needle Aspiration (FNA) Needles, Core Biopsy Needles
Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Industry Trends: What’s Reshaping Demand?
Leading companies operating in the endoscopic ultrasound (EUS)-guided fine needle aspiration market are focusing on enhancing needle technologies, including endoscopic ultrasound fine biopsy needles, to improve precision and the quantity of tissue acquired during procedures. Endoscopic ultrasound fine biopsy needles are specialized instruments designed to obtain core tissue samples during EUS-guided procedures, enabling a more accurate histological diagnosis compared to conventional aspiration needles. For instance, in May 2024, Cook Medical, a US-based medical device company, launched the EchoTip ClearCore EUS Biopsy Needle, a next-generation device intended for precision biopsies of gastrointestinal lesions. This 22-gauge needle is employed with an ultrasound endoscope for fine needle biopsies (FNB) of submucosal and extramural lesions, mediastinal masses, lymph nodes, and intraperitoneal masses situated near or within the gastrointestinal tract. It incorporates a cobalt chromium Franseen tip for superior sharpness, allowing tissue puncture with minimal force and precise control, and a flexible, spring-coiled sheath that facilitates access to challenging anatomical locations.
Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Company Landscape And Competitive Strategy
Major companies operating in the endoscopic ultrasound (eus)-guided fine needle aspiration market are Medtronic plc, Fujifilm Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Steris plc, Cook Medical LLC, Canon Medical Systems Corporation, CONMED Corporation, Pentax Medical, Argon Medical Devices Inc., Fannin Limited, Zhejiang Soudon Medical Technology Co. Ltd., Micro-Tech Endoscopy USA Inc., CIVCO Medical Solutions, Medorah Meditek Pvt. Ltd., ACE Medical Devices Pvt. Ltd., ENDO-FLEX GmbH, Limaca Medical Ltd., Medi-Globe GmbH, ZKSK Medical Technology Co. Ltd.
View The Full Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Report:
Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the endoscopic ultrasound (EUS)-guided fine needle aspiration market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic ultrasound (eus)-guided fine needle aspiration market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
